CVAC logo

CureVac NV (CVAC) EBITDA

annual EBITDA:

$226.96M+$483.08M(+188.61%)
December 31, 2024

Summary

  • As of today (June 2, 2025), CVAC annual EBITDA is $226.96 million, with the most recent change of +$483.08 million (+188.61%) on December 31, 2024.
  • During the last 3 years, CVAC annual EBITDA has risen by +$684.24 million (+149.63%).
  • CVAC annual EBITDA is now at all-time high.

Performance

CVAC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

quarterly EBITDA:

-$49.19M-$11.99M(-32.24%)
March 1, 2025

Summary

  • As of today (June 2, 2025), CVAC quarterly EBITDA is -$49.19 million, with the most recent change of -$11.99 million (-32.24%) on March 1, 2025.
  • Over the past year, CVAC quarterly EBITDA has increased by +$21.07 million (+29.99%).
  • CVAC quarterly EBITDA is now -111.92% below its all-time high of $412.68 million, reached on September 30, 2024.

Performance

CVAC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

TTM EBITDA:

$255.27M+$21.07M(+9.00%)
March 1, 2025

Summary

  • As of today (June 2, 2025), CVAC TTM EBITDA is $255.27 million, with the most recent change of +$21.07 million (+9.00%) on March 1, 2025.
  • Over the past year, CVAC TTM EBITDA has increased by +$524.25 million (+194.90%).
  • CVAC TTM EBITDA is now at all-time high.

Performance

CVAC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CVAC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+188.6%+30.0%+194.9%
3 y3 years+149.6%-951.2%+175.2%
5 y5 years+321.6%-119.1%+405.6%

CVAC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+149.6%-111.9%+62.3%at high+175.2%
5 y5-yearat high+149.6%-111.9%+71.7%at high+149.3%
alltimeall timeat high+149.6%-111.9%+71.7%at high+149.3%

CVAC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$49.19M(+32.2%)
$255.27M(+9.0%)
Dec 2024
$226.96M(-188.6%)
-$37.19M(-109.0%)
$234.20M(+27.3%)
Sep 2024
-
$412.68M(-681.0%)
$183.97M(-167.0%)
Jun 2024
-
-$71.02M(+1.1%)
-$274.61M(+2.1%)
Mar 2024
-
-$70.25M(-19.6%)
-$268.98M(+6.3%)
Dec 2023
-$256.13M(+8.9%)
-$87.42M(+90.4%)
-$253.09M(-14.6%)
Sep 2023
-
-$45.91M(-29.8%)
-$296.19M(+1.8%)
Jun 2023
-
-$65.39M(+20.3%)
-$290.98M(+4.6%)
Mar 2023
-
-$54.36M(-58.4%)
-$278.21M(+21.7%)
Dec 2022
-$235.30M
-$130.52M(+220.7%)
-$228.53M(+133.4%)
Sep 2022
-
-$40.70M(-22.6%)
-$97.89M(-55.2%)
Jun 2022
-
-$52.62M(+1024.6%)
-$218.54M(-35.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$4.68M(-4361.6%)
-$339.56M(-26.5%)
Dec 2021
-$457.28M(+312.5%)
$109.80K(-100.1%)
-$462.20M(-10.7%)
Sep 2021
-
-$161.35M(-7.1%)
-$517.45M(+31.1%)
Jun 2021
-
-$173.65M(+36.4%)
-$394.56M(+76.0%)
Mar 2021
-
-$127.32M(+130.9%)
-$224.23M(+87.9%)
Dec 2020
-$110.86M(+8.2%)
-$55.14M(+43.4%)
-$119.36M(+13.0%)
Sep 2020
-
-$38.46M(+1059.3%)
-$105.61M(+21.6%)
Jun 2020
-
-$3.32M(-85.2%)
-$86.86M(+4.0%)
Mar 2020
-
-$22.45M(-45.7%)
-$83.54M(+0.3%)
Dec 2019
-$102.44M(+29.3%)
-$41.38M(+110.0%)
-$83.26M(+98.8%)
Sep 2019
-
-$19.71M(-11.1%)
-$41.87M(+88.9%)
Mar 2019
-
-$22.17M
-$22.17M
Dec 2018
-$79.20M
-
-

FAQ

  • What is CureVac NV annual EBITDA?
  • What is the all time high annual EBITDA for CureVac NV?
  • What is CureVac NV annual EBITDA year-on-year change?
  • What is CureVac NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CureVac NV?
  • What is CureVac NV quarterly EBITDA year-on-year change?
  • What is CureVac NV TTM EBITDA?
  • What is the all time high TTM EBITDA for CureVac NV?
  • What is CureVac NV TTM EBITDA year-on-year change?

What is CureVac NV annual EBITDA?

The current annual EBITDA of CVAC is $226.96M

What is the all time high annual EBITDA for CureVac NV?

CureVac NV all-time high annual EBITDA is $226.96M

What is CureVac NV annual EBITDA year-on-year change?

Over the past year, CVAC annual EBITDA has changed by +$483.08M (+188.61%)

What is CureVac NV quarterly EBITDA?

The current quarterly EBITDA of CVAC is -$49.19M

What is the all time high quarterly EBITDA for CureVac NV?

CureVac NV all-time high quarterly EBITDA is $412.68M

What is CureVac NV quarterly EBITDA year-on-year change?

Over the past year, CVAC quarterly EBITDA has changed by +$21.07M (+29.99%)

What is CureVac NV TTM EBITDA?

The current TTM EBITDA of CVAC is $255.27M

What is the all time high TTM EBITDA for CureVac NV?

CureVac NV all-time high TTM EBITDA is $255.27M

What is CureVac NV TTM EBITDA year-on-year change?

Over the past year, CVAC TTM EBITDA has changed by +$524.25M (+194.90%)
On this page